abstract |
The invention provides compounds of formula (I): n n n n n n n n n n n n wherein R 1 and R 2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors. |